Subscribe to RSS
DOI: 10.1055/s-0029-1245153
© Georg Thieme Verlag KG Stuttgart · New York
Erreger bei Tumoren der okulären Adnexe
Infectious Agents in Ocular Adnexal TumoursPublication History
Eingegangen: 7.9.2009
Angenommen: 18.1.2010
Publication Date:
09 June 2010 (online)

Zusammenfassung
In den vergangenen Jahren wurden Erreger zunehmend als ein wichtiger pathogenetischer Faktor verschiedener maligner Tumoren der okulären Adnexe erkannt. Viele dieser Viren und Bakterien beeinflussen den Zellzyklus und die physiologische Apoptose. Lymphome der okulären Adnexe, insbesondere das extranodale Marginalzonenlymphom, werden in manchen Regionen durch Chlamydophila psittaci und Helicobacter pylori verursacht. Epstein-Barr-Viren scheinen bei dem Natural-Killer/T-Zell-Lymphom-Subtyp eine Rolle zu spielen, wie sie bei dem Burkitt-Lymphom bereits länger bekannt ist. Bakterien scheinen eine reaktive lymphoide Proliferation zu induzieren, während Viren direkt die lymphoiden Zellen befallen und den Zellzyklus beeinflussen und die Apoptose unterdrücken mit der nachfolgenden malignen Entartung. Im Allgemeinen sind Proteine, die zur Zellzyklusprogression führen, wie z. B. das Retinoblastomprotein, erhöht und Eiweiße, die den Zellzyklusfortgang unterdrücken (wie z. B. p16 und p21) abwesend oder funktionsuntüchtig. Die Inaktivierung von p53 durch Mutation seines Gens führt zu einer Erhöhung eines defekten p53 Proteins und zur Einschränkung der Apoptose, wodurch die onkogenen Zufallsmutationen wirksam werden können. Die konjunktivale intraepitheliale Neoplasie (CIN) ist im Vergleich zu dem Pendant der Zervix, der zervikalen intraepithelialen Neoplasie, weniger häufig mit einer HPV-Infektion verbunden. Aufgrund der CIN-Lokalisation scheinen besonders UVB-Strahlen eine Rolle bei ihrer Entstehung zu spielen, wodurch es zu einer p53-Inaktivierung und nachfolgender Hemmung der Apoptose kommt. HIV-Positivität scheint ebenfalls die Entwicklung von CIN und Bindehautkarzinomen zu begünstigen, in den letzten Jahren mit zunehmender Fallzahl. Das Kaposi-Sarkom tritt bei HIV-infizierten Personen selten an der okulären Adnexe auf und scheint mit dem kaposi-sarkomaassoziierten Herpes-Virus (KSHV) oder HHV8 zusammenzuhängen. Das KSHV-assoziierte Latency Associated Nuclear Antigen (LANA) Protein bindet an den negativen Regulator Glycogen-Synthase Kinase-3 (GSK-3), und bedingt im Kern eine zellzyklusabhängige Ansammlung von GSK-3, welches Beta-Catenin stabilisiert und seine Konzentration erhöht. Die neuen Erkenntnisse über diese verschiedenartigen Erreger und Zellzyklusbeeinträchtigungen mögen einen Einfluss auf die Entwicklung neuer therapeutischer Strategien haben.
Abstract
In recent years, infectious agents have been increasingly recognised as an important pathogenetic factor for various malignant tumours of the ocular adnexa. Many of these viruses and bacteria affect the cell cycle and physiological apoptosis. Ocular adnexal lymphoma (OAL), especially extranodal marginal cell lymphoma, is associated with Chlamydophila psittaci and Helicobacter pylori in certain geographic regions. Epstein-Barr virus seems to play a role in the natural killer/T-cell lymphoma subtype of the orbit, as has long been described for Burkitt lymphoma. Bacteria seem to induce reactive lymphoid proliferation, while viruses directly infect the lymphoid cells, affecting the cell cycle and suppressing apoptosis, with subsequent malignant transformation. In general, proteins leading to cell cycle progression, like retinoblastoma protein, are elevated, and proteins inhibiting cell cycle progression, like p16 and p21, are absent or unable to function normally. Inactivation of p53 by mutation of its DNA, which leads to elevation of defective p53 protein and inhibition of apoptosis, allows oncogenic by-chance mutations to become effective. Conjunctival intraepithelial neoplasia (CIN) is less strongly associated with HPV infection than is cervical intraepithelial neoplasia. Based on the localisation of CIN, ultraviolet B radiation seems to play a primary role, leading to p53 inactivation and subsequent inhibition of apoptosis. HIV positivity also seems to aid the development of CIN and conjunctival squamous cell carcinoma, with an increasing number of cases during recent years. Kaposi sarcoma rarely occurs at the ocular adnexa in HIV-positive individuals and seems to be associated with Kaposi sarcoma-associated Herpes virus (KSHV) or HHV8. The KSHV-encoded latency associated nuclear antigen (LANA) protein binds to the negative regulator glycogen-synthase kinase-3 (GSK-3), causing a cell cycle-dependent nuclear accumulation of GSK-3, which stabilises beta-catenin and increases its levels. The findings regarding these various infectious agents and cell cycle alterations might aid the development of new therapeutic strategies.
Schlüsselwörter
okuläre Tumoren - Pharmakologie - Infektiologie
Key words
pharmacology - ocular tumours - infectious diseases
Literatur
- 1
Abrams J T, Balin B J, Vonderheid E C.
Association between Sezary T cell-activating factor, Chlamydia pneumoniae, and cutaneous
T cell lymphoma.
Ann N Y Acad Sci.
2001;
941
69-85
MissingFormLabel
- 2
Anttila T I, Lehtinen T, Leinonen M. et al .
Serological evidence of an association between chlamydial infections and malignant
lymphomas.
Br J Haematol.
1998;
103
150-156
MissingFormLabel
- 3
Ateenyi-Agaba C.
Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda.
Lancet.
1995;
345
695-696
MissingFormLabel
- 4
Ateenyi-Agaba C, Weiderpass E, Tommasino M. et al .
Papillomavirus infection in the conjunctiva of individuals with and without AIDS:
an autopsy series from Uganda.
Cancer Lett.
2006;
239
98-102
MissingFormLabel
- 5
Auw-Haedrich C, Coupland S E, Kapp A. et al .
Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification.
Br J Ophthalmol.
2001;
85
63-69
MissingFormLabel
- 6
Bayerdorffer E, Neubauer A, Rudolph B. et al .
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after
cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
Lancet.
1995;
345
1591-1594
MissingFormLabel
- 7
Beral V, Bull D, Darby S. et al .
Risk of Kaposi’s sarcoma and sexual practices associated with faecal contact in homosexual
or bisexual men with AIDS.
Lancet.
1992;
339
632-635
MissingFormLabel
- 8
Bosch F X, Lorincz A, Munoz N. et al .
The causal relation between human papillomavirus and cervical cancer.
J Clin Pathol.
2002;
55
244-265
MissingFormLabel
- 9
Cartron G, Dacheux L, Salles G. et al .
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in
IgG Fc receptor FcgammaRIIIa gene.
Blood.
2002;
99
754-758
MissingFormLabel
- 10
Chan C C, Shen D, Mochizuki M. et al .
Detection of Helicobacter Pylori and Chlamydia Pneumoniae Genes in Primary Orbital
Lymphoma.
Trans Am Ophthalmol Soc.
2006;
104
62-70
MissingFormLabel
- 11
Chang Y, Cesarman E, Pessin M S. et al .
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma.
Science.
1994;
266
1865-1869
MissingFormLabel
- 12
Chanudet E, Zhou Y, Bacon C M. et al .
Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different
geographical regions.
J Pathol.
2006;
209
344-351
MissingFormLabel
- 13
Chisi S K, Kollmann M K, Karimurio J.
Conjunctival squamous cell carcinoma in patients with human immunodeficiency virus
infection seen at two hospitals in Kenya.
East Afr Med J.
2006;
83
267-270
MissingFormLabel
- 14
Coiffier B.
Rituximab in combination with CHOP improves survival in elderly patients with aggressive
non-Hodgkin’s lymphoma.
Tumori.
2002;
88
S26-S28
MissingFormLabel
- 15
Coupland S E, Foss H D, Anagnostopoulos I. et al .
Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas
of the ocular adnexa.
Invest Ophthalmol Vis Sci.
1999;
40
555-562
MissingFormLabel
- 16
Coupland S E, Foss H D, Assaf C. et al .
T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues:
a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Ophthalmology.
1999;
106
2109-2120
MissingFormLabel
- 17
Daibata M, Nemoto Y, Togitani K. et al .
Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients.
Br J Haematol.
2006;
132
651-652
MissingFormLabel
- 18
Cremoux de P, Subtil A, Ferreri A J. et al .
Re: Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.
J Natl Cancer Inst.
2006;
98
365-366
MissingFormLabel
- 19
De Vita S, Sansonno D, Dolcetti R. et al .
Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed
cryoglobulinemia.
Blood.
1995;
86
1887-1892
MissingFormLabel
- 20
Demidem A, Lam T, Alas S. et al .
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell
line to cell killing by cytotoxic drugs.
Cancer Biother Radiopharm.
1997;
12
177-186
MissingFormLabel
- 21
Dugel P U, Gill P S, Frangieh G T. et al .
Treatment of ocular adnexal Kaposi’s sarcoma in acquired immune deficiency syndrome.
Ophthalmology.
1992;
99
1127-1132
MissingFormLabel
- 22
Eng H L, Lin T M, Chen S Y. et al .
Failure to detect human papillomavirus DNA in malignant epithelial neoplasms of conjunctiva
by polymerase chain reaction.
Am J Clin Pathol.
2002;
117
429-436
MissingFormLabel
- 23
Feltgen N, Auw-Hadrich C.
[Exceptional conjunctival tumor in a young allergic woman].
Ophthalmologe.
2005;
102
1204-1206
MissingFormLabel
- 24
Ferreri A J, Guidoboni M, Ponzoni M. et al .
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.
J Natl Cancer Inst.
2004;
96
586-594
MissingFormLabel
- 25
Ferreri A J, Ponzoni M, Guidoboni M. et al .
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic
therapy.
J Clin Oncol.
2005;
23
5067-5073
MissingFormLabel
- 26
Ferreri A J, Ponzoni M, Guidoboni M. et al .
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter
prospective trial.
J Natl Cancer Inst.
2006;
98
1375-1382
MissingFormLabel
- 27
Ferreri A J, Ponzoni M, Martinelli G. et al .
Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the
ocular adnexa.
Haematologica.
2005;
90
1578-1579
MissingFormLabel
- 28
Fogla R, Biswas J, Kumar S K. et al .
Squamous cell carcinoma of the conjunctiva as initial presenting sign in a patient
with acquired immunodeficiency syndrome (AIDS) due to human immunodeficiency virus
type-2.
Eye.
2000;
14 (Pt 2)
246-267
MissingFormLabel
- 29
Foran J M, Rohatiner A Z, Cunningham D. et al .
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for
patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell
lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
J Clin Oncol.
2000;
18
317-324
MissingFormLabel
- 30
Ford J N, Jennings P A, Spradbrow P B. et al .
Evidence for papillomaviruses in ocular lesions in cattle.
Res Vet Sci.
1982;
32
257-259
MissingFormLabel
- 31
Franzin F, Efremov D G, Pozzato G. et al .
Clonal B-cell expansions in peripheral blood of HCV-infected patients.
Br J Haematol.
1995;
90
548-552
MissingFormLabel
- 32
Frucht-Pery J, Sugar J, Baum J. et al .
Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter
experience.
Ophthalmology.
1997;
104
2085-2093
MissingFormLabel
- 33
Gates A E, Kaplan L D.
AIDS malignancies in the era of highly active antiretroviral therapy.
Oncology (Williston Park).
2002;
16
657-665, discussion 665, 668 – 670
MissingFormLabel
- 34
Ghabrial R, Quivey J M, Dunn J P. et al .
Radiation therapy of acquired immunodeficiency syndrome-related Kaposi’s sarcoma of
the eyelids and conjunctiva.
Arch Ophthalmol.
1992;
110
1423-1426
MissingFormLabel
- 35
Giaconi J A, Karp C L.
Current treatment options for conjunctival and corneal intraepithelial neoplasia.
Ocul Surf.
2003;
1
66-73
MissingFormLabel
- 36
Goebel Jr N, Serr A, Mittelviefhaus H. et al .
Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma-is there an association?
The German experience.
Leuk Res.
2007;
31
1450-1452
MissingFormLabel
- 37
Goedert J J.
The epidemiology of acquired immunodeficiency syndrome malignancies.
Semin Oncol.
2000;
27
390-401
MissingFormLabel
- 38
Goedert J J, Cote T R.
Conjunctival malignant disease with AIDS in USA.
Lancet.
1995;
346
257-258
MissingFormLabel
- 39
Gracia E, Froesch P, Mazzucchelli L. et al .
Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients.
Leuk Lymphoma.
2007;
48
104-108
MissingFormLabel
- 40
Grünberger B, Hauff W, Lukas J. et al .
”Blind” antibiotic treatment targeting Chlamydia is not effective in patients with
MALT lymphoma of the ocular adnexa.
Ann Oncol.
2006;
17
484-487
MissingFormLabel
- 41
Gunalp I, Gunduz K, Duruk K.
Orbital exenteration: a review of 429 cases.
Int Ophthalmol.
1995;
19
177-184
MissingFormLabel
- 42
Hasche H, Eck M, Lieb W.
[Immunochemical demonstration of human herpes virus 8 in conjunctival Kaposi’s sarcoma].
Ophthalmologe.
2003;
100
142-144
MissingFormLabel
- 43
Heinz C, Fanihagh F, Steuhl K P.
Squamous cell carcinoma of the conjunctiva in patients with atopic eczema.
Cornea.
2003;
22
135-137
MissingFormLabel
- 44
Hirst L W.
Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia:
early resolution.
Ophthalmology.
2007;
114
976-982
MissingFormLabel
- 45
Hummer J, Gass J D, Huang A J.
Conjunctival Kaposi’s sarcoma treated with interferon alpha-2a.
Am J Ophthalmol.
1993;
116
502-503
MissingFormLabel
- 46
Jazirehi A R, Vega M I, Chatterjee D. et al .
Inhibition of the Raf-MEK1 / 2-ERK1 / 2 signaling pathway, Bcl-xL down-regulation,
and chemosensitization of non-Hodgkin’s lymphoma B cells by Rituximab.
Cancer Res.
2004;
64
7117-7126
MissingFormLabel
- 47
Jung S M, Lin H C, Chu P H. et al .
Expression of cell cycle-regulatory proteins, MIB-1, p16, p53, and p63, in squamous
cell carcinoma of conjunctiva: not associated with human papillomavirus infection.
Virchows Arch.
2006;
448
301-305
MissingFormLabel
- 48
Kallen C, Reinhard T, Schilgen G. et al .
[Atopic keratoconjunctivitis: probably a risk factor for the development of conjuntival
carcinoma].
Ophthalmologe.
2003;
100
808-814
MissingFormLabel
- 49
Kaposi M.
Idiopatisches multiples Pigmentsarkom der Haut.
Arch Dermatol Syph.
1872;
4
265
MissingFormLabel
- 50
Karcioglu Z A, Issa T M.
Human papilloma virus in neoplastic and non-neoplastic conditions of the external
eye.
Br J Ophthalmol.
1997;
81
595-598
MissingFormLabel
- 51
Karp C L, Scott I U, Chang T S. et al .
Conjunctival intraepithelial neoplasia. A possible marker for human immunodeficiency
virus infection?.
Arch Ophthalmol.
1996;
114
257-261
MissingFormLabel
- 52
Kedes D H, Operskalski E, Busch M. et al .
The seroepidemiology of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus):
distribution of infection in KS risk groups and evidence for sexual transmission.
Nat Med.
1996;
2
918-924
MissingFormLabel
- 53
Kiire C A, Dhillon B.
The aetiology and associations of conjunctival intraepithelial neoplasia.
Br J Ophthalmol.
2006;
90
109-113
MissingFormLabel
- 54
Kirova Y M, Belembaogo E, Frikha H. et al .
Radiotherapy in the management of epidemic Kaposi’s sarcoma: a retrospective study
of 643 cases.
Radiother Oncol.
1998;
46
19-22
MissingFormLabel
- 55
Klein G, Pearson G, Henle G. et al .
Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt
tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV
reactivities of different sera.
J Exp Med.
1969;
129
697-705
MissingFormLabel
- 56
Knowles D M, Athan E, Ubriaco A. et al .
Extranodal noncutaneous lymphoid hyperplasias represent a continuous spectrum of B-cell
neoplasia: demonstration by molecular genetic analysis.
Blood.
1989;
73
1635-1645
MissingFormLabel
- 57
Kurumety U R, Lustbader J M.
Kaposi’s sarcoma of the bulbar conjunctiva as an initial clinical manifestation of
acquired immunodeficiency syndrome.
Arch Ophthalmol.
1995;
113
978
MissingFormLabel
- 58
Lauer S A, Malter J S, Meier J R.
Human papillomavirus type 18 in conjunctival intraepithelial neoplasia.
Am J Ophthalmol.
1990;
110
23-27
MissingFormLabel
- 59
Laurila A L, Anttila T, Laara E. et al .
Serological evidence of an association between Chlamydia pneumoniae infection and
lung cancer.
Int J Cancer.
1997;
74
31-34
MissingFormLabel
- 60
Lecuit M, Suarez F, Lortholary O.
[Immunoproliferative small intestinal disease associated with Campylobacter jejuni].
Med Sci (Paris).
2004;
20
638-640
MissingFormLabel
- 61
Lee G A, Hirst L W.
Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year
survey.
Arch Ophthalmol.
1992;
110
525-527
MissingFormLabel
- 62
Lee S B, Au Eong K G, Saw S M. et al .
Eye cancer incidence in Singapore.
Br J Ophthalmol.
2000;
84
767-770
MissingFormLabel
- 63
Levin I, Romano S, Steinberg M. et al .
Lymphogranuloma Venereum: Rectal Stricture and Carcinoma.
Dis Colon Rectum.
1964;
7
129-134
MissingFormLabel
- 64
Liu Y C, Ohyashiki J H, Ito Y. et al .
Chlamydia psittaci in ocular adnexal lymphoma: Japanese experience.
Leuk Res.
2006;
30
1587-1589
MissingFormLabel
- 65
Luppi M, Longo G, Ferrari M G. et al .
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type.
Br J Haematol.
1996;
94
373-375
MissingFormLabel
- 66
Malik M O, El Sheikh E H.
Tumors of the eye and adnexa in the Sudan.
Cancer.
1979;
44
293-303
MissingFormLabel
- 67
Malope B I, Pfeiffer R M, Mbisa G. et al .
Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children
in a South African population.
J Acquir Immune Defic Syndr.
2007;
44
351-355
MissingFormLabel
- 68
Mathas S, Rickers A, Bommert K. et al .
Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular
signaling pathways.
Cancer Res.
2000;
60
7170-7176
MissingFormLabel
- 69
McDonnell J M, Mayr A J, Martin W J.
DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva
and cornea.
N Engl J Med.
1989;
320
1442-1446
MissingFormLabel
- 70
McDonnell J M, McDonnell P J, Sun Y Y.
Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival
epithelial neoplasia.
Invest Ophthalmol Vis Sci.
1992;
33
184-189
MissingFormLabel
- 71
McLaughlin P, Grillo-Lopez A J, Link B K. et al .
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:
half of patients respond to a four-dose treatment program.
J Clin Oncol.
1998;
16
2825-2833
MissingFormLabel
- 72
Moslehi R, Devesa S S, Schairer C. et al .
Rapidly increasing incidence of ocular non-hodgkin lymphoma.
J Natl Cancer Inst.
2006;
98
936-939
MissingFormLabel
- 73
Moubayed P, Mwakyoma H, Schneider D T.
High frequency of human papillomavirus 6 / 11, 16, and 18 infections in precancerous
lesions and squamous cell carcinoma of the conjunctiva in subtropical Tanzania.
Am J Clin Pathol.
2004;
122
938-943
MissingFormLabel
- 74
Muccioli C, Belfort Jr R, Burnier M. et al .
Squamous cell carcinoma of the conjunctiva in a patient with the acquired immunodeficiency
syndrome.
Am J Ophthalmol.
1996;
121
94-96
MissingFormLabel
- 75
Mulder M M, Heddema E R, Pannekoek Y. et al .
No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci
in a cohort of patients from the Netherlands.
Leuk Res.
2006;
30
1305-1307
MissingFormLabel
- 76
Nakamura Y, Mashima Y, Kameyama K. et al .
Detection of human papillomavirus infection in squamous tumours of the conjunctiva
and lacrimal sac by immunohistochemistry, in situ hybridisation, and polymerase chain
reaction.
Br J Ophthalmol.
1997;
81
308-313
MissingFormLabel
- 77
Newton R, Ferlay J, Reeves G. et al .
Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma
of the eye.
Lancet.
1996;
347
1450-1451
MissingFormLabel
- 78
Newton R, Ziegler J, Ateenyi-Agaba C. et al .
The epidemiology of conjunctival squamous cell carcinoma in Uganda.
Br J Cancer.
2002;
87
301-308
MissingFormLabel
- 79
Nuckel H, Meller D, Steuhl K P. et al .
Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.
Eur J Haematol.
2004;
73
258-262
MissingFormLabel
- 80
Paavonen J, Vesterinen E, Meyer B. et al .
Genital Chlamydia trachomatis infections in patients with cervical atypia.
Obstet Gynecol.
1979;
54
289-291
MissingFormLabel
- 81
Panda A, Bajaj M S, Balasubramanya R. et al .
Topical mitomycin C for conjunctival-corneal squamous cell carcinoma.
Am J Ophthalmol.
2003;
135
122-123, author reply 123 – 124
MissingFormLabel
- 82
Poole T R.
Conjunctival squamous cell carcinoma in Tanzania.
Br J Ophthalmol.
1999;
83
177-179
MissingFormLabel
- 83
Reff M E, Carner K, Chambers K S. et al .
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD 20.
Blood.
1994;
83
435-445
MissingFormLabel
- 84
Rigacci L, Nassi L, Puccioni M. et al .
Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.
Ann Hematol.
2007;
86
565-568
MissingFormLabel
- 85
Roggero E, Zucca E, Mainetti C. et al .
Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma
of the skin.
Hum Pathol.
2000;
31
263-268
MissingFormLabel
- 86
Rosado M F, Byrne G E, Ding Jr F. et al .
Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with
no evidence for an association with Chlamydia psittaci.
Blood.
2006;
107
467-472
MissingFormLabel
- 87
Rose P P, Bogyo M, Moses A V. et al .
Insulin-like Growth Factor II Receptor-mediated intracellular Retention of Cathepsin
B is essential for transformation of endothelial cells by Kaposi’s sarcoma associated
herpesvirus.
J Virol.
2007;
81 (15)
8050-8062
MissingFormLabel
- 88
Sacchi S, Pozzi S, Marcheselli R. et al .
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of
patients with recurrent follicular lymphoma.
Cancer.
2007;
110
121-128
MissingFormLabel
- 89
Saegusa M, Takano Y, Hashimura M. et al .
HPV type 16 in conjunctival and junctional papilloma, dysplasia, and squamous cell
carcinoma.
J Clin Pathol.
1995;
48
1106-1110
MissingFormLabel
- 90
Schechter B A, Nagler R S.
Successful treatment with 5-Fu.
Ophthalmology.
2003;
110
1262-1263, author reply 1263
MissingFormLabel
- 91
Schmack I, Kruse F E, Bauer A. et al .
[Neurodermatitis. A risk factor for the development of squamous cell carcinoma].
Ophthalmologe.
2006;
103
141-143
MissingFormLabel
- 92
Scott I U, Karp C L, Nuovo G J.
Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia.
Ophthalmology.
2002;
109
542-547
MissingFormLabel
- 93
Shan D, Ledbetter J A, Press O W.
Apoptosis of malignant human B cells by ligation of CD 20 with monoclonal antibodies.
Blood.
1998;
91
1644-1652
MissingFormLabel
- 94
Shields C L, Demirci H, Karatza E. et al .
Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors.
Ophthalmology.
2004;
111
1747-1754
MissingFormLabel
- 95
Shields J A, Shields C L, De Potter P.
Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture.
Arch Ophthalmol.
1997;
115
808-815
MissingFormLabel
- 96
Shields J A, Shields C L, Suvarnamani C. et al .
Orbital exenteration with eyelid sparing: indications, technique, and results.
Ophthalmic Surg.
1991;
22
292-297
MissingFormLabel
- 97
Shimoyama Y, Oyama T, Asano N. et al .
Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini
review.
J Clin Exp Hematop.
2006;
46
1-4
MissingFormLabel
- 98
Shipp M A.
Prognostic factors in aggressive non-Hodgkin’s lymphoma: who has ”high-risk” disease?.
Blood.
1994;
83
1165-1173
MissingFormLabel
- 99
Sjo N C, Foegh P, Juhl B R. et al .
Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma.
Ophthalmology.
2007;
114
182-186
MissingFormLabel
- 100
Smith J S, Munoz N, Herrero R. et al .
Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology
of invasive cervical cancer in Brazil and the Philippines.
J Infect Dis.
2002;
185
324-331
MissingFormLabel
- 101 Spencer W H. Chapter 2: Conjunctiva. Spencer, WH Ophthalmic Pathology: an atlas and textbook Philadelphia; WB Saunders 1996 2nd ed
MissingFormLabel
- 102
Sun E C, Fears T R, Goedert J J.
Epidemiology of squamous cell conjunctival cancer.
Cancer Epidemiol Biomarkers Prev.
1997;
6
73-77
MissingFormLabel
- 103
Timm A, Stropahl G, Schittowski M. et al .
[Association of malignant tumors of the conjunctiva and HIV infection in Kinshasa
(D. R. Congo). First results].
Ophthalmologe.
2004;
101
1011-1016
MissingFormLabel
- 104
Tulvatana W, Bhattarakosol P, Sansopha L. et al .
Risk factors for conjunctival squamous cell neoplasia: a matched case-control study.
Br J Ophthalmol.
2003;
87
396-398
MissingFormLabel
- 105
Tuppurainen K, Raninen A, Kosunen O. et al .
Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ
hybridization and polymerase chain reaction.
Acta Ophthalmol (Copenh).
1992;
70
248-254
MissingFormLabel
- 106
Vargas R L, Fallone E, Felgar R E. et al .
Is there an association between ocular adnexal lymphoma and infection with Chlamydia
psittaci? The University of Rochester experience.
Leuk Res.
2006;
30
547-551
MissingFormLabel
- 107
Viejo-Borbolla A, Schulz T F.
Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and
pathogenesis.
AIDS Rev.
2003;
5
222-229
MissingFormLabel
- 108
Waddell K M, Downing R G, Lucas S B. et al .
Corneo-conjunctival carcinoma in Uganda.
Eye.
2006;
20
893-899
MissingFormLabel
- 109
Walboomers J M, Jacobs M V, Manos M M. et al .
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
J Pathol.
1999;
189
12-19
MissingFormLabel
- 110
Woog J J, Kim Y D, Yeatts R P. et al .
Natural killer/T-cell lymphoma with ocular and adnexal involvement.
Ophthalmology.
2006;
113
140-147
MissingFormLabel
- 111
Wotherspoon A C, Ortiz-Hidalgo C, Falzon M R. et al .
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.
Lancet.
1991;
338
1175-1176
MissingFormLabel
- 112
You C, Ryu M, Huh J. et al .
Ocular adnexal lymphoma is highly associated with Chlamydia psittaci.
Eur J Cancer.
2005;
3
282-283
MissingFormLabel
- 113
Zinzani P L, Alinari L, Stefoni V. et al .
Rituximab in primary conjunctiva lymphoma.
Leuk Res.
2005;
29
107-108
MissingFormLabel
Prof. Dr. Claudia Auw-Hädrich
Universitäts-Augenklinik Freiburg
Killianstr. 5
79106 Freiburg
Phone: ++ 49/7 61/2 70 41 95
Fax: ++ 49/7 61/2 70 40 57
Email: claudia.auw-haedrich@uniklinik-freiburg.de